Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophtalmia in patients with primary Sjögren's syndrome;Pilocarpina oral en el tratamientode la xerostomía y xeroftalmía en pacientes con síndrome de Sjögren primario

Medicina Clinica

Volumn 122, Issue 7, 2004, Pages 253-255

  Solans, Roser ^a   Bosch, José Ángel ^a   Selva, Albert ^a   Simeón, Carmen Pilar ^a   Fonollosa, Vicente ^a   Vilardell, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Pilocarpin; Prymary Sj gren's syndrome

Indexed keywords

PILOCARPINE; ROSE BENGAL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; LACRIMAL GLAND; MALE; QUESTIONNAIRE; SCHIRMER TEST; SCINTIGRAPHY; SJOEGREN SYNDROME; STAINING; SWEAT GLAND; SYMPTOM; XEROPHTHALMIA; XEROSTOMIA;

EID: 1842814990     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13058373     Document Type: Article

References (10)

1. Fox RI, Stern M, Michelson P. Update in Sjögren syndrome. Curr Op Rheumatol 2000;12:391-8.
2. Selva O'Callaghan A, Bosch Gil JA, Solans Laqué R, Segura García A, Armadans Gil L, Mijares Boeckh-Behrens T, et al. Síndrome de Sjögren primario: caracteristicas clínicas e inmunológicas de 114 pacientes. Med Clin (Barc) 2001;116:721-5.
3. García-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, Calvo-Alen J, Cervera R, et al. Primary Sjögren Síndrome. Clinical and immunological patterns in a cohort of 400 patients. Medicine (Baltimore) 2002;81:270-80.
4. Thomas E, Hay EM, Hajeer A, Silman J. Sjögren syndrome: a community-based study of prevalence and impact. Br J Rheumatol 1998;37:1069-76.
5. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth. Gerodontology 1986;5:75-99.
6. Mei L, Roeske WR, Izutsu KT, Yamamuroa HI. Characterization of muscarinic acetylcholine receptors in human labial salivary glands. Eur J Pharmacol 1990;176:367-70.
7. Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 1995;49:143-55.
8. Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL, Tran-Jhonson TK, et al. Pilocarpine tablests for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomised, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med 1999;159:174-81.
9. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bersntein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum 1993;36:340-7.
10. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Clasification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.